Journal of Infection, Journal Year: 2025, Volume and Issue: unknown, P. 106442 - 106442

Published: Feb. 1, 2025

Highlights•First meta-analysis evaluating the clinical efficacy of amubarvimab-romlusevimab in COVID-19 patients•Meta-analysis included five studies with a total 1,665 patients from diverse settings•Amubarvimab-romlusevimab treatment did not show significant reduction mortality or morbidity.

Language: Английский